These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 24387952)

  • 21. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I; Mammen AL
    Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and classification of idiopathic inflammatory myopathies.
    Lundberg IE; Miller FW; Tjärnlund A; Bottai M
    J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and Management of Immune-Mediated Myopathies.
    Milone M
    Mayo Clin Proc; 2017 May; 92(5):826-837. PubMed ID: 28473041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acquired necrotizing myopathies].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2013 Jun; 34(6):363-8. PubMed ID: 22998975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
    Allenbach Y; Keraen J; Bouvier AM; Jooste V; Champtiaux N; Hervier B; Schoindre Y; Rigolet A; Gilardin L; Musset L; Charuel JL; Boyer O; Jouen F; Drouot L; Martinet J; Stojkovic T; Eymard B; Laforêt P; Behin A; Salort-Campana E; Fain O; Meyer A; Schleinitz N; Mariampillai K; Grados A; Benveniste O
    Brain; 2016 Aug; 139(Pt 8):2131-5. PubMed ID: 27086869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease.
    Sordet C; Goetz J; Sibilia J
    Joint Bone Spine; 2006 Dec; 73(6):646-54. PubMed ID: 17110150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Idiopathic inflammatory myopathies].
    Vencovský J
    Vnitr Lek; 2018; 64(2):155-163. PubMed ID: 29595280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
    J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myositis-specific autoantibodies].
    Gran JT; Molberg Ø; Dobloug GC; Andersson H; Taraldsrud E; Scheie D
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1631-4. PubMed ID: 19721478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Idiopathic Inflammatory Myopathies].
    Tomaras S; Kekow J; Feist E
    Dtsch Med Wochenschr; 2020 Jul; 145(13):903-910. PubMed ID: 32615605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a novel myositis-associated antibody directed against cortactin.
    Labrador-Horrillo M; Martínez MA; Selva-O'Callaghan A; Trallero-Araguás E; Grau-Junyent JM; Vilardell-Tarrés M; Juarez C
    Autoimmun Rev; 2014 Oct; 13(10):1008-12. PubMed ID: 25182205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Jobanputra R; Dankó K
    Acta Reumatol Port; 2015; 40(4):337-47. PubMed ID: 26922197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.